Medicare Part B and Part D cover all out-of-pocket costs for common vaccines, including vaccines for the flu, pneumonia, ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...

The Trump administration’s decision to revoke Harvard University’s ability to enroll international students raises ...

The university’s Center for Vaccine Development is recruiting people for a study into pre-existing flu immunity in healthy adults.

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...

Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...